GlassScriptPhysician profile
Heiko Pohl
NPI 1356465348
$5,047.30
in general payments reported to CMS, 2019-2025
8 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.46 · 2023: $38.00 · 2024: $4,309 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,820 · Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,820.00 |
| Food and Beverage | $196.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $2,474.43 | 2024 | Cologuard Collection Kit |
| Pentax of America, INC. | $1,750.00 | 2024 | |
| Olympus Corporation | $670.00 | 2025 | Single Use Electrosurgical Snare Sd-400 |
| Micro-Tech Endoscopy USA, INC. | $84.41 | 2024 | |
| Olympus Corporation of The Americas | $38.00 | 2023 | Evis Exera Lll Colonovideoscope, Evis Exera III Gastrointestinal Videoscope |
| Apollo Endosurgery US INC | $30.46 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heiko Pohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.